Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody

As the coronavirus disease 2019 (COVID-19) pandemic continues, there is a strong need for highly potent monoclonal antibodies (mAbs) that are resistant against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VoCs). Here, we evaluate the potency of the previously des...

Descripción completa

Detalles Bibliográficos
Autores principales: Torres, Jonathan L., Ozorowski, Gabriel, Andreano, Emanuele, Liu, Hejun, Copps, Jeffrey, Piccini, Giulia, Donnici, Lorena, Conti, Matteo, Planchais, Cyril, Planas, Delphine, Manganaro, Noemi, Pantano, Elisa, Paciello, Ida, Pileri, Piero, Bruel, Timothée, Montomoli, Emanuele, Mouquet, Hugo, Schwartz, Olivier, Sala, Claudia, De Francesco, Raffaele, Wilson, Ian A., Rappuoli, Rino, Ward, Andrew B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2022
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171815/
https://www.ncbi.nlm.nih.gov/pubmed/35549549
http://dx.doi.org/10.1073/pnas.2120976119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171815/
https://www.ncbi.nlm.nih.gov/pubmed/35549549
http://dx.doi.org/10.1073/pnas.2120976119

Ejemplares similares